Artal Group S.A. reported 2 positions worth $931.12M for the quarter ended Jun 30, 2026, down 7.9% on the prior quarter. It opened 0 new positions, added to 1, trimmed 1 and exited 0. Its largest holding is Cava Group, Inc. at 54.9% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Change | Trade Value | Weight |
|---|---|---|---|
| LXRX Lexicon Pharmaceuticals, Inc. | +20.42M +13.2% | $49.01M | 45.15% |
| Holding | Change | Trade Value | Weight |
|---|---|---|---|
| CAVA Cava Group, Inc. | -3.00M -31.6% | $235.44M | 54.85% |
No new positions this quarter.
No positions were closed this quarter.
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | CAVA Cava Group, Inc. | Consumer Discretionary | 6.51M | $510.75M | 54.85% | -3.00M | -31.6% | Reduced | 5.59% |
| 2 | LXRX Lexicon Pharmaceuticals, Inc. | Healthcare | 175.16M | $420.37M | 45.15% | +20.42M | +13.2% | Added | 39.2% |
Tip. Select a row to see that position’s full history at Artal.
As of its Q2 2026 13F filing, Artal Group S.A.’s five largest positions were Cava Group, Inc. (CAVA) at 54.9%, Lexicon Pharmaceuticals, Inc. (LXRX) at 45.1% of the reported portfolio.
Artal Group S.A. reported a 13F portfolio worth $931.12M across 2 positions for Q2 2026. That is down 7.9% from the previous quarter.
Its largest purchases by value were Lexicon Pharmaceuticals, Inc. ($49.01M). It opened 0 new positions.
Its largest sales by value were Cava Group, Inc. ($235.44M). It exited 0 positions entirely.
From the Form 13F-HR reports Artal Group S.A. files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.